Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
about
The role of serotonin 5-HT2A receptors in memory and cognitionNeuroimaging biomarkers of neurodegenerative diseases and dementiaPsychedelicsExercise benefits brain function: the monoamine connection5-HT radioligands for human brain imaging with PET and SPECTKefir protective effects against nicotine cessation-induced anxiety and cognition impairments in ratsNeurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.Prevalence and characteristics of allodynia in headache sufferers: a population study.The serotonergic system and cognitive functionBehavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detectionCurrent therapeutic targets for the treatment of Alzheimer's disease.Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.Current status of positron emission tomography radiotracers for serotonin receptors in humans.Current radiosynthesis strategies for 5-HT2A receptor PET tracers.Amygdala functional connectivity is associated with locus of control in the context of cognitive aging.Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain.Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.Molecular imaging of serotonin degeneration in mild cognitive impairment.No observable relationship between the 12 genes of nervous system and reasoning skill in a young Chinese Han population.Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.
P2860
Q26779278-F771949F-B3EB-4354-A0A3-5E906486F84CQ27691820-A7362861-267F-4000-84C7-2A74EDDDE8FAQ30359998-C26024E1-4118-4CBB-8A8E-8CED742003D2Q33772106-2D703581-B96E-49EC-A3D5-7702C863BE5FQ34192729-C0C89692-E744-4297-B56D-A7EC12E7A606Q34813538-A1172ADF-0970-4DE0-AA85-102B78568C40Q36020776-5409C327-6BB6-4661-8DBF-6E78BA35671AQ36724965-8D3FCEE8-96F4-4BBC-965D-DBD647A495EBQ37092481-0944B0F9-3F1D-4447-BD60-1C5508B7E097Q37148294-0C4FB1B9-D80A-49A5-99BF-1BB86BFF5F74Q37245282-28D6F361-4AC0-4C6A-B245-79ACE966CCDFQ37395530-8C907F86-18E8-4325-AD7F-9506A7826E5EQ37639158-F7FD6CC8-C95C-4BDA-B6A1-BEFA411E0AF9Q37737296-2408CFEC-092E-4E7B-A9DB-566EF1CEE1C9Q37790804-908F7B42-6116-47AD-9B8D-95A3A92F68D7Q38081485-94D7463E-81AB-4841-90A5-674D938C9943Q38166965-328E207B-4F8B-4DA2-B00C-5FA8338CA8B2Q38495731-002DD808-7493-485E-9BD2-080A1159FF1FQ38743326-9F752DB5-767E-4C35-BF35-52D82A97E0F0Q45330207-DD2CB252-E2DE-4A63-AFEA-682D8797E184Q47095864-0DB380D8-0555-4F19-996B-3333DB14B765Q48143733-E2E100EF-9429-40BC-893D-24CBA8CB3D83Q50583224-6E14B758-D1A3-4E12-A465-C87708E29595Q51891355-F31E9876-0308-4900-B63F-3ADFCD0EDD13Q55399027-750B1C58-7EF4-435C-A26B-B844D1E103A7
P2860
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@ast
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@en
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@nl
type
label
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@ast
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@en
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@nl
prefLabel
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@ast
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@en
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@nl
P50
P1476
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
@en
P2093
P304
P356
10.1016/J.NEUROBIOLAGING.2007.04.011
P50
P577
2007-06-04T00:00:00Z